[Status and prospect of antibody-directed targeting treatment for hepatocellular carcinoma].
Yang
Dong-hua
DH
Department of Gastroenterology, The First Affiliated Hospital of Jinan University, Guangzhou 510630, China. thdyang@163.com
D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D000912:Antibodies, Neoplasm / Q000276:immunology* / Q000627:therapeutic use; D000915:Antibody Affinity; D000918:Antibody Specificity; D000937:Antigen-Antibody Reactions; D000951:Antigens, Neoplasm / Q000032:analysis / Q000276:immunology; D006528:Carcinoma, Hepatocellular / Q000276:immunology / Q000628:therapy*; D006801:Humans; D008113:Liver Neoplasms / Q000276:immunology / Q000628:therapy*
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm